BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to reduce short- and long-term complications associated with transvenous ICD leads. Early multicenter studies included younger patients with less left ventricular systolic dysfunction and fewer comorbidities th...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!